Changing levels of sex hormones and calcitonin gene-related peptide (CGRP) during a woman’s life: Implications for the efficacy and safety of novel antimigraine medications
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
This publication has 44 references indexed in Scilit:
- Sex Differences in the Prevalence, Symptoms, and Associated Features of Migraine, Probable Migraine and Other Severe Headache: Results of the American Migraine Prevalence and Prevention (AMPP) StudyHeadache: The Journal of Head and Face Pain, 2013
- Effects of menopausal status on circulating calcitonin gene-related peptide and adipokines: implications for insulin resistance and cardiovascular risksClimacteric, 2008
- Expression of calcitonin gene-related peptide, adrenomedullin, and receptor modifying proteins in human adipose tissue and alteration in their expression with menopause statusMenopause, 2007
- Circulating calcitonin gene-related peptide and its placental origins in normotensive and preeclamptic pregnanciesAmerican Journal of Obstetrics and Gynecology, 2006
- The CGRP-Antagonist, BIBN4096BS Does not Affect Cerebral or Systemic Haemodynamics in Healthy VolunteersCephalalgia, 2005
- Involvement of calcitonin gene-related peptide in control of human fetoplacental vascular toneAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Calcitonin gene-related peptide in pregnancy and its emerging receptor heterogeneityTrends in Endocrinology & Metabolism, 2002
- Transvaginal uterine and umbilical artery Doppler examination of 12–16 weeks and the subsequent development of pre‐eclampsia and intrauterine growth retardationUltrasound in Obstetrics & Gynecology, 1997
- Vasoactive peptide release in the extracerebral circulation of humans during migraine headacheAnnals of Neurology, 1990
- Calcitonin gene-related peptide is a potent vasodilatorNature, 1985